Your browser doesn't support javascript.
loading
Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement.
Owens, Douglas K; Davidson, Karina W; Krist, Alex H; Barry, Michael J; Cabana, Michael; Caughey, Aaron B; Doubeni, Chyke A; Epling, John W; Kubik, Martha; Landefeld, C Seth; Mangione, Carol M; Pbert, Lori; Silverstein, Michael; Tseng, Chien-Wen; Wong, John B.
Afiliação
  • Owens DK; Veterans Affairs Palo Alto Health Care System, Palo Alto, California.
  • Davidson KW; Stanford University, Stanford, California.
  • Krist AH; Feinstein Institute for Medical Research at Northwell Health, Manhasset, New York.
  • Barry MJ; Fairfax Family Practice Residency, Fairfax, Virginia.
  • Cabana M; Virginia Commonwealth University, Richmond.
  • Caughey AB; Harvard Medical School, Boston, Massachusetts.
  • Doubeni CA; University of California, San Francisco.
  • Epling JW; Oregon Health & Science University, Portland.
  • Kubik M; Mayo Clinic, Rochester, New York.
  • Landefeld CS; Virginia Tech Carilion School of Medicine, Roanoke.
  • Mangione CM; Temple University, Philadelphia, Pennsylvania.
  • Pbert L; University of Alabama at Birmingham.
  • Silverstein M; University of California, Los Angeles.
  • Tseng CW; University of Massachusetts Medical School, Worcester.
  • Wong JB; Boston University, Boston, Massachusetts.
JAMA ; 322(9): 857-867, 2019 09 03.
Article em En | MEDLINE | ID: mdl-31479144

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Moduladores Seletivos de Receptor Estrogênico / Inibidores da Aromatase Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tamoxifeno / Neoplasias da Mama / Moduladores Seletivos de Receptor Estrogênico / Inibidores da Aromatase Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Middle aged Idioma: En Revista: JAMA Ano de publicação: 2019 Tipo de documento: Article País de publicação: Estados Unidos